U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...
New NIH network to recruit thousands for late-stage COVID-19 vaccine trials
By
Alicia Lasek
Jul 09, 2020
A nationwide clinical trial network will test promising COVID-19 vaccines and antibodies. There are five possible vaccine candidates.
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
By
Alicia Lasek
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...
Coronavirus vaccines must take elders’ weaker immune systems into account: report
By
Alicia Lasek
Jun 23, 2020
Residents’ weaker immune systems could dilute the effectiveness of future coronavirus vaccines. Solutions are in the works, finds a new report.
Are we done with COVID? Is COVID done with us?
By
Jean Wendland Porter
Jul 25, 2023
At last. I haven’t worn a mask in public in months, I’m starting to see friends again, I’m eating in restaurants again, and my new normal is the old normal. Life is good. There’s some hesitation...